Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?
Cancers - Switzerland
doi 10.3390/cancers11091269
Full Text
Open PDFAbstract
Available in full text
Date
August 29, 2019
Authors
Publisher
MDPI AG